CHICAGO (May 19, 2021)—Dina, an AI-powered care-at-home platform and network, announced that Robert “Bob” Maluso has been named the company’s chief growth officer, overseeing national sales and marketing. He will work out of the company’s Atlanta hub.
Maluso most recently served as senior vice president of business development and marketing at WoundTech, the leader in technology-enabled wound management services. He is also a licensed nuclear pharmacist in the state of Ohio.
Prior to WoundTech, Maluso was vice president of business development at Prognos, and vice president of payer market sales at AllScripts, where he managed national sales teams and executed multi-million dollar deals in the payer sector.
“Bob’s deep experience working with health plans will help us expand our role as convenors of home-based services and continue to bridge the gap between payers and providers,” said Dina CEO Ashish V. Shah. “His leadership will be instrumental to our growth in several key market segments: Medicare Advantage, Managed Medicaid and risk-bearing provider organizations. We are delighted that he is joining us in our mission to support more people in their homes and communities.”
"Dina’s AI-powered at-home care platform fills critical needs in the post-acute and at-home spaces. I believe we are poised for exponential growth in both the hospital and health plan markets and I am thrilled to join the team,” Maluso said.
Maluso’s appointment follows major funding news from Dina: In January, the company closed a $7 million Series A funding round led by Philadelphia-based Osage Venture Partners along with existing investors, strategic partners, and Wheaton, Ill.-based First Trust Capital Partners.
Visit dinacare.com for more information.
